Determining clinically meaningful thresholds for innovative burn care products to reduce autograft: A US burn surgeon Delphi panel
Open Access
- 9 November 2020
- journal article
- research article
- Published by Elsevier BV in Clinical Dermatology and Surgery
- Vol. 47 (5), 1066-1073
- https://doi.org/10.1016/j.burns.2020.10.022
Abstract
No abstract availableKeywords
Funding Information
- Mallinckrodt Pharmaceuticals
This publication has 18 references indexed in Scilit:
- Using the modified Delphi method to establish clinical consensus for the diagnosis and treatment of patients with rotator cuff pathologyBMC Medical Research Methodology, 2016
- Outcome of Burns Treated with Autologous Cultured Proliferating Epidermal Cells: A Prospective Randomized Multicenter Intrapatient Comparative TrialCell Transplantation, 2016
- Comparison of the Application of Allogeneic Fibroblast and Autologous Mesh Grafting With the Conventional Method in the Treatment of Third-Degree BurnsJournal of Burn Care & Research, 2016
- Burn wound healing and treatment: review and advancementsCritical Care, 2015
- Glyaderm® dermal substitute: Clinical application and long-term results in 55 patientsBurns, 2015
- Contracture of skin graft in human burns: Effect of artificial dermisBurns, 2014
- Using and Reporting the Delphi Method for Selecting Healthcare Quality Indicators: A Systematic ReviewPLOS ONE, 2011
- Use of an autologous bioengineered composite skin in extensive burns: Clinical and functional outcomes. A multicentric studyClinical Dermatology and Surgery, 2011
- Dermal substitution with Matriderm® in burns on the dorsum of the handBurns, 2010
- Clinical Application and Long-Term Follow-Up Study of Porcine Acellular Dermal Matrix Combined With Autoskin GraftingJournal of Burn Care & Research, 2010